Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
为什么Arcutis Biotherapeutics的股票交易价格上涨了29％；以下是20只股票，盘前走势
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.
Arcutis Biotherapeutics, Inc.（纳斯达克股票代码：ARQT）的股价在今天的盘前交易中大幅上涨，此前该公司公布的第一季度财务业绩好于预期。
Arcutis Biotherapeutics reported quarterly earnings of 32 cents per share which beat the analyst consensus estimate of losses of 73 cents. Quarterly sales clocked in at $49.57 million, beating the analyst consensus estimate of $14.68 million, according to data from Benzinga Pro.
Arcutis Biotherapeutics公布的季度每股收益为32美分，超过了分析师普遍预期的73美分亏损。根据Benzinga Pro的数据，季度销售额为4,957万美元，超过了分析师普遍预期的1468万美元。
Arcutis Biotherapeutics shares jumped 29% to $10.49 in the pre-market trading session.
Arcutis Biotherapeutics的股价在盘前交易时段上涨了29％，至10.49美元。
Here are some other stocks moving in pre-market trading.
以下是盘前交易中其他一些股票。
Gainers
获胜者
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 113.8% to $0.6098 in pre-market trading after...
法拉第未来智能电气公司（纳斯...
登录免费看全文
登录/注册